Introduction of Imatinib as First-line Therapy for Chronic Myeloid Leukemia in Cuba
INTRODUCTION Chronic myeloid leukemia is the rst malignant disease to be associated with a genetic lesion and is the first leuke-mia to provide a genotype model conducive to targeted molecular therapy. It is a chronic clonal myeloproliferative disorder, originating in a pluripotent stem cell co...
Uloženo v:
| Vydáno v: | MEDICC Review |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medical Education Cooperation with Cuba
2011
|
| Témata: | |
| On-line přístup: | https://www.redalyc.org/articulo.oa?id=437542077009 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
